Literature DB >> 6433977

Possible role for peptide-oligosaccharide interactions in differential oligosaccharide processing at asparagine-107 of the light chain and asparagine-297 of the heavy chain in a monoclonal IgG1 kappa.

G Savvidou, M Klein, A A Grey, K J Dorrington, J P Carver.   

Abstract

The carbohydrate attached at Asn-107 of the light chain of a human myeloma IgG1 kappa (Hom) was isolated and the structure determined by 1H NMR. Two oligosaccharides were found corresponding to mono- and disialylated forms of the bisected biantennary class of glycopeptides. Both structures had Fuc alpha 1-6 linked to the GlcNAc residue attached to Asn and NeuNAc residues linked alpha 2-6. Because of the unusual nature of these structures, the Asn-297 oligosaccharides of the same IgG were prepared from Fc fragments and heavy chains. Comparison of the structures of the latter glycopeptides with structures from the same site on a second human myeloma IgG1 kappa (Tem) showed them to be quite similar in that the majority of the structures were biantennary but not bisected. We suggest that the completely bisected nature of the light-chain oligosaccharides comes from a high level of activity of GlcNAc-T-III (the enzyme responsible for the attachment of the bisecting GlcNAc) in the cells producing the IgG. We suggest a mechanism for differential glycosylation between the Asn-107 and Asn-297 sites based on the stabilization of the Asn-297 oligosaccharide in a conformation with the torsional angle omega about the C5-C6 bond of the Man alpha 1-6 linkage equal to -60 degrees. It has previously been postulated that this conformation is not a substrate for GlcNAc-T-III [Brisson, J.-R., & Carver, J. P. (1983) Can. J. Biochem. 61, 1067-1078].(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433977     DOI: 10.1021/bi00311a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

2.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Interaction of asparagine-linked oligosaccharides with an immobilized rice (Oryza sativa) lectin column.

Authors:  I Poola; S Narasimhan
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

4.  Lectin analysis of human immunoglobulin G N-glycan sialylation.

Authors:  M Dalziel; I McFarlane; J S Axford
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

5.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

6.  Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.

Authors:  Zhiqun Tang; Rency S Varghese; Slavka Bekesova; Christopher A Loffredo; Mohamed Abdul Hamid; Zuzana Kyselova; Yehia Mechref; Milos V Novotny; Radoslav Goldman; Habtom W Ressom
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

7.  Glycosylation of ovalbumin in a heterologous cell: analysis of oligosaccharide chains of the cloned glycoprotein in mouse L cells.

Authors:  B T Sheares; P W Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase.

Authors:  M Sousa; A J Parodi
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

Review 9.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

10.  Interactions and three-dimensional localization of a group of nuclear pore complex proteins.

Authors:  N Panté; R Bastos; I McMorrow; B Burke; U Aebi
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.